QA: Contrafect Corp in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001478069_2023_Contrafect_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001478069, Contrafect Corp

  xvar xval
0 AssetsCurrent 17,706,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 627,000
3 remainder_Assets 2,346,000
4 LiabilitiesCurrent 20,840,000
5 LiabilitiesNoncurrent 2,392,000
6 remainder_Liabilities 9,299,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,151,000
9 ResearchAndDevelopmentExpense 44,738,000
10 remainder_Expenses 7,719,000
11 remainder_Revenues 0
12 remainder_NetIncome -545,000
13 remainder_ComprehensiveNetIncome 52,000
  yvar yval
0 Assets 20,679,000
1 Liabilities 32,531,000
2 Expenses 64,608,000
3 Revenues 0
4 StockholdersEquity -11,852,000
5 NetIncome -65,153,000
6 ComprehensiveNetIncome -65,127,000
7 BaseVar 59,207,500
8 EconomicCapitalRatiobeforeLimitedLiability -3.42
9 EconomicCapitalRatio 0.554

Edgar->Model Mapping

Feature Distribution

Change over Time